Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BLMH | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-11 |
mRNA | MEX3A | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-11 |
mRNA | RP11-426L16.10 | CTRPv2 | pan-cancer | AAC | -0.23 | 8e-11 |
mRNA | MYOF | CTRPv2 | pan-cancer | AAC | -0.22 | 9e-11 |
mRNA | SSRP1 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-10 |
mRNA | SMIM8 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-10 |
mRNA | HNRNPU | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-10 |
mRNA | CENPV | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-10 |
mRNA | RHOC | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-10 |
mRNA | NUP133 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-10 |